What smart money is saying about GSK plc
GSK
No fund has written a full thesis on GSK plc in our archive, but 1 fund letter reports a position in it — most recently BA Beutel Goodman World Value Fund in March 2026.
1
Reported positions
0
Bought
1
Sold
2
Letters
Position history
Every position in GSK plc on record in the archive was reported in Q1 2026, across 1 fund letter — 1 trimmed or exited.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q1 2026 | 1 | 0 | 1 | 0 |
Fund activity · 1 position · 1 move
- March 2026
“We completed process-driven, one-third sales during the period as DBS, GSK, Amgen and SMC as the stocks reached our target prices.”
Read the letterGSK plc
Also mentioned · 1
These funds discuss GSK plc — as a competitor, benchmark or comparable — without disclosing a position in it.
- June 2026
“and a trial has been set for July 14-17.”
Read the letterGSK plc
Read the letters behind these GSK plc positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger